星空体育官方入口网站网址大全-登录入口官网

#瓣膜性#

56篇内容 | 1179人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1798280, encodeId=69fc1e9828066, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Eur Heart J：多发瓣膜性心脏病患者的特征、治疗和结局, objectType=article, longId=726036, objectId=f3efe2603633, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3efe2603633, replyNumber=0, likeNumber=67, createdTime=2023-03-15, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3efe2603633, moduleTitle=Eur Heart J：多发瓣膜性心脏病患者的特征、治疗和结局, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f3efe2603633)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798277, encodeId=5e811e9827789, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Br J Clin Pharmacol：非瓣膜性房颤遇上肝病，直接口服抗凝剂的使用和长期疗效, objectType=article, longId=217659, objectId=afdf21e659f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afdf21e659f3, replyNumber=0, likeNumber=57, createdTime=2022-06-06, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afdf21e659f3, moduleTitle=Br J Clin Pharmacol：非瓣膜性房颤遇上肝病，直接口服抗凝剂的使用和长期疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=afdf21e659f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798276, encodeId=71211e98276cc, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=2021 ESC：利伐沙班显著降低肾功能保留的非瓣膜性房颤患者的肾功能下降风险, objectType=article, longId=216628, objectId=47192166282f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47192166282f, replyNumber=0, likeNumber=60, createdTime=2022-03-26, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47192166282f, moduleTitle=2021 ESC：利伐沙班显著降低肾功能保留的非瓣膜性房颤患者的肾功能下降风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=47192166282f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798279, encodeId=e7b31e98279b0, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=J Cardiol：非瓣膜性心房颤动合并急性心力衰竭患者使用艾多沙班治疗的D-二聚体水平变化分析, objectType=article, longId=295735, objectId=5c33295e3598, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c33295e3598, replyNumber=0, likeNumber=78, createdTime=2022-09-29, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c33295e3598, moduleTitle=J Cardiol：非瓣膜性心房颤动合并急性心力衰竭患者使用艾多沙班治疗的D-二聚体水平变化分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5c33295e3598)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798278, encodeId=d8e41e98278e5, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=BMJ：心脏复律可降低新诊断非瓣膜性房颤患者不良预后风险, objectType=article, longId=219448, objectId=7088219448e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7088219448e5, replyNumber=0, likeNumber=66, createdTime=2022-04-15, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7088219448e5, moduleTitle=BMJ：心脏复律可降低新诊断非瓣膜性房颤患者不良预后风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7088219448e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798274, encodeId=ab5e1e98274ab, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Eur Heart J：非瓣膜性房颤患者持续服用口服抗凝药的预测因子、时间进程和结局, objectType=article, longId=214455, objectId=7be82144553e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7be82144553e, replyNumber=0, likeNumber=65, createdTime=2022-03-07, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7be82144553e, moduleTitle=Eur Heart J：非瓣膜性房颤患者持续服用口服抗凝药的预测因子、时间进程和结局, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7be82144553e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798272, encodeId=5fab1e9827260, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=JAHA：血压变异性对非瓣膜性房颤患者不良事件的影响, objectType=article, longId=205054, objectId=cefe2050546c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cefe2050546c, replyNumber=0, likeNumber=55, createdTime=2021-10-10, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cefe2050546c, moduleTitle=JAHA：血压变异性对非瓣膜性房颤患者不良事件的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cefe2050546c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798275, encodeId=f0251e98275f9, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=对于非瓣膜性房颤使用新型抗凝药物的用量如何确定？, objectType=article, longId=214673, objectId=3ca32146e3e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ca32146e3e5, replyNumber=0, likeNumber=58, createdTime=2022-03-29, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ca32146e3e5, moduleTitle=对于非瓣膜性房颤使用新型抗凝药物的用量如何确定？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3ca32146e3e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798273, encodeId=2d2f1e98273a9, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=JACC：糖尿病前期也可增加非瓣膜性房颤患者的卒中风险, objectType=article, longId=207827, objectId=3f7620e82759, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f7620e82759, replyNumber=0, likeNumber=65, createdTime=2021-07-27, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f7620e82759, moduleTitle=JACC：糖尿病前期也可增加非瓣膜性房颤患者的卒中风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3f7620e82759)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798269, encodeId=ed0e1e982691f, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Heart：瓣膜性风湿心脏病孕妇不良心脏事件的预测, objectType=article, longId=197916, objectId=71c819e9169d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71c819e9169d, replyNumber=0, likeNumber=56, createdTime=2021-04-29, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71c819e9169d, moduleTitle=Heart：瓣膜性风湿心脏病孕妇不良心脏事件的预测, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=71c819e9169d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798268, encodeId=fa061e9826834, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=JACC：N末端B型利钠肽前体可以预测瓣膜性心脏病的死亡风险, objectType=article, longId=191964, objectId=eba119196470, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eba119196470, replyNumber=0, likeNumber=53, createdTime=2020-07-08, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eba119196470, moduleTitle=JACC：N末端B型利钠肽前体可以预测瓣膜性心脏病的死亡风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=eba119196470)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798270, encodeId=3add1e9827024, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=EUR HEART J-CARD PHA：利伐沙班与华法林对非瓣膜性心房颤动和冠状动脉或外周动脉疾病患者的有效性和安全性如何？, objectType=article, longId=198584, objectId=2f96198584fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f96198584fb, replyNumber=0, likeNumber=56, createdTime=2021-06-17, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f96198584fb, moduleTitle=EUR HEART J-CARD PHA：利伐沙班与华法林对非瓣膜性心房颤动和冠状动脉或外周动脉疾病患者的有效性和安全性如何？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2f96198584fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798271, encodeId=33eb1e98271f5, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=梅斯心血管|EHJ：无症状瓣膜性心脏病(VHD)怎么治？是对症下药还是提前干预！, objectType=article, longId=200670, objectId=cd492006e03f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd492006e03f, replyNumber=0, likeNumber=67, createdTime=2020-10-21, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd492006e03f, moduleTitle=梅斯心血管|EHJ：无症状瓣膜性心脏病(VHD)怎么治？是对症下药还是提前干预！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cd492006e03f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798267, encodeId=e4a01e9826733, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Stroke：非瓣膜性房颤患者卒中发作后早期开始直接口服抗凝药对短期和长期结局的影响, objectType=article, longId=186699, objectId=44a91866995e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44a91866995e, replyNumber=0, likeNumber=70, createdTime=2020-12-03, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44a91866995e, moduleTitle=Stroke：非瓣膜性房颤患者卒中发作后早期开始直接口服抗凝药对短期和长期结局的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=44a91866995e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798266, encodeId=93131e982660b, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=中国老年瓣膜性心脏病注册：半数为二尖瓣反流，知晓率不足20%, objectType=article, longId=178773, objectId=ee951e877314, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee951e877314, replyNumber=0, likeNumber=67, createdTime=2020-05-23, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee951e877314, moduleTitle=中国老年瓣膜性心脏病注册：半数为二尖瓣反流，知晓率不足20%, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ee951e877314)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798264, encodeId=98301e98264ef, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Chest：非瓣膜性房颤患者四种口服抗凝血剂的有效性和安全性评估, objectType=article, longId=166308, objectId=02b116630814, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02b116630814, replyNumber=0, likeNumber=65, createdTime=2019-05-28, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02b116630814, moduleTitle=Chest：非瓣膜性房颤患者四种口服抗凝血剂的有效性和安全性评估, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=02b116630814)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798260, encodeId=993a1e9826019, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=JACC：不同尺寸主动脉瓣环中使用自扩张与球囊扩张瓣膜进行TAVR后瓣膜性能的比较, objectType=article, longId=156102, objectId=6cc315610275, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cc315610275, replyNumber=0, likeNumber=57, createdTime=2019-04-30, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cc315610275, moduleTitle=JACC：不同尺寸主动脉瓣环中使用自扩张与球囊扩张瓣膜进行TAVR后瓣膜性能的比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6cc315610275)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798265, encodeId=7fea1e982657b, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Heart：瓣膜性心脏病和生物人工心脏瓣膜的房颤患者口服抗凝剂疗效, objectType=article, longId=168552, objectId=9d6b1685522f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d6b1685522f, replyNumber=0, likeNumber=61, createdTime=2019-10-24, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d6b1685522f, moduleTitle=Heart：瓣膜性心脏病和生物人工心脏瓣膜的房颤患者口服抗凝剂疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9d6b1685522f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798263, encodeId=7c651e982636b, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=2019 ESO指南：卒中或短暂性脑缺血发作以及非瓣膜性房颤患者卒中和其他血栓栓塞事件二级预防抗栓治疗, objectType=article, longId=165554, objectId=60da165554b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60da165554b1, replyNumber=0, likeNumber=57, createdTime=2019-09-08, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60da165554b1, moduleTitle=2019 ESO指南：卒中或短暂性脑缺血发作以及非瓣膜性房颤患者卒中和其他血栓栓塞事件二级预防抗栓治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=60da165554b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798262, encodeId=ebaa1e9826292, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=2019ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS适用性标准：非瓣膜性心脏病心脏结构和功能多峰成像评估, objectType=article, longId=158248, objectId=3c941582481a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c941582481a, replyNumber=0, likeNumber=72, createdTime=2019-10-06, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c941582481a, moduleTitle=2019ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS适用性标准：非瓣膜性心脏病心脏结构和功能多峰成像评估, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3c941582481a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

瓣膜性

2020-05-29

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Eur Heart J：多发瓣膜性心脏病患者的特征、治疗和结局

2023-03-15

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Br J Clin Pharmacol：非瓣膜性房颤遇上肝病，直接口服抗凝剂的使用和长期疗效

2022-06-06

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

2021 ESC：利伐沙班显著降低肾功能保留的非瓣膜性房颤患者的肾功能下降风险

2022-03-26

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

J Cardiol：非瓣膜性心房颤动合并急性心力衰竭患者使用艾多沙班治疗的D-二聚体水平变化分析

2022-09-29

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

BMJ：心脏复律可降低新诊断非瓣膜性房颤患者不良预后风险

2022-04-15

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Eur Heart J：非瓣膜性房颤患者持续服用口服抗凝药的预测因子、时间进程和结局

2022-03-07

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

JAHA：血压变异性对非瓣膜性房颤患者不良事件的影响

2021-10-10

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

对于非瓣膜性房颤使用新型抗凝药物的用量如何确定？

2022-03-29

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

JACC：糖尿病前期也可增加非瓣膜性房颤患者的卒中风险

2021-07-27

一叶知秋 (审核中...)

前往app查看评论内容

#瓣膜性#

Heart：瓣膜性风湿心脏病孕妇不良心脏事件的预测

2021-04-29

一叶知秋 (审核中...)

前往app查看评论内容

#瓣膜性#

JACC：N末端B型利钠肽前体可以预测瓣膜性心脏病的死亡风险

2020-07-08

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

EUR HEART J-CARD PHA：利伐沙班与华法林对非瓣膜性心房颤动和冠状动脉或外周动脉疾病患者的有效性和安全性如何？

2021-06-17

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

梅斯心血管|EHJ：无症状瓣膜性心脏病(VHD)怎么治？是对症下药还是提前干预！

2020-10-21

一叶知秋 (审核中...)

前往app查看评论内容

#瓣膜性#

Stroke：非瓣膜性房颤患者卒中发作后早期开始直接口服抗凝药对短期和长期结局的影响

2020-12-03

一叶知秋 (审核中...)

前往app查看评论内容

#瓣膜性#

中国老年瓣膜性心脏病注册：半数为二尖瓣反流，知晓率不足20%

2020-05-23

一叶知秋 (审核中...)

前往app查看评论内容

#瓣膜性#

Chest：非瓣膜性房颤患者四种口服抗凝血剂的有效性和安全性评估

2019-05-28

一叶知秋 (审核中...)

前往app查看评论内容

#瓣膜性#

JACC：不同尺寸主动脉瓣环中使用自扩张与球囊扩张瓣膜进行TAVR后瓣膜性能的比较

2019-04-30

一叶知秋 (审核中...)

前往app查看评论内容

#瓣膜性#

Heart：瓣膜性心脏病和生物人工心脏瓣膜的房颤患者口服抗凝剂疗效

2019-10-24

一叶知秋 (审核中...)

前往app查看评论内容

#瓣膜性#

2019 ESO指南：卒中或短暂性脑缺血发作以及非瓣膜性房颤患者卒中和其他血栓栓塞事件二级预防抗栓治疗

2019-09-08

一叶知秋 (审核中...)

前往app查看评论内容

#瓣膜性#

2019ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS适用性标准：非瓣膜性心脏病心脏结构和功能多峰成像评估

2019-10-06

科室
- - 订阅+
  - 更多科室
工具
服务